日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5

多巴胺受体 D2 通过 MET 和死亡受体 4/5 调节胶质母细胞瘤的存活和死亡

Hye-Min Jeon, Young Taek Oh, Yong Jae Shin, Nakho Chang, Donggeun Kim, Donghun Woo, Yoon Yeup, Kyeung Min Joo, Heejin Jo, Heekyoung Yang, Jin-Ku Lee, Wonyoung Kang, Jason Sa, Won Jun Lee, James Hale, Justin D Lathia, Benjamin Purow, Myung Jin Park, Jong Bae Park, Do-Hyun Nam, Jeongwu Lee

A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma

贝伐单抗治疗复发性和难治性脑膜瘤的多机构 II 期临床试验

Priya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, Marc C Chamberlain, David Schiff, Patrick Y Wen, Fabio Massaiti Iwamoto, Demirkan Besim Gursel, David A Reardon, Benjamin Purow, Masha Kocherginski, Irene Helenowski, Jeffrey J Raizer

Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition

数据驱动的计算模型确定了胶质母细胞瘤对 SHP2 抑制反应的决定因素

Evan K Day, Qing Zhong, Benjamin Purow, Matthew J Lazzara

ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers

ERK依赖性自杀基因疗法选择性靶向RTK/RAS驱动的癌症

Evan K Day,Anne Campbell,Ashley Pandolf,Troy Rogerson,Qing Zhong,Aizhen Xiao,Benjamin Purow,Matthew J Lazzara

Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner

技术选择以模型依赖的方式显著改变了对免疫功能正常的小鼠神经胶质瘤的适应性免疫反应

Breanna Noffsinger, Alexandra Witter, Natasha Sheybani, Aizhen Xiao, Laryssa Manigat, Qing Zhong, Suchet Taori, Tajie Harris, Tim Bullock, Richard Price, Benjamin Purow

Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling

可通过阻断 FGFR-SPRY2 旁路信号来克服胶质母细胞瘤细胞对 EGFR 和 MET 抑制的耐药性

Evan K Day, Nisha G Sosale, Aizhen Xiao, Qing Zhong, Benjamin Purow, Matthew J Lazzara

Statins affect human glioblastoma and other cancers through TGF-β inhibition

他汀类药物通过抑制 TGF-β 影响人类胶质母细胞瘤和其他癌症

Aizhen Xiao, Breanna Brenneman, Desiree Floyd, Laurey Comeau, Kelsey Spurio, Inan Olmez, Jeongwu Lee, Ichiro Nakano, Jakub Godlewski, Agnieszka Bronisz, Noritaka Kagaya, Kazuo Shin-Ya, Benjamin Purow

Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma

c-Met/Trk 联合抑制可克服胶质母细胞瘤对 CDK4/6 抑制剂的耐药性

Inan Olmez, Ying Zhang, Laryssa Manigat, Mouadh Benamar, Breanna Brenneman, Ichiro Nakano, Jakub Godlewski, Agnieszka Bronisz, Jeongwu Lee, Tarek Abbas, Roger Abounader, Benjamin Purow

FHL2 interacts with EGFR to promote glioblastoma growth

FHL2 与 EGFR 相互作用促进胶质母细胞瘤生长

Lili Sun, Shuye Yu, Hui Xu, Yanwen Zheng, Juntang Lin, Meiyan Wu, Jide Wang, Aidong Wang, Qing Lan, Frank Furnari, Webster Cavenee, Benjamin Purow, Ming Li

Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms

CDK4/6 和 mTOR 联合抑制通过多种机制对胶质母细胞瘤具有协同作用

Inan Olmez ,Breanna Brenneman ,Aizhen Xiao ,Vlad Serbulea ,Mouadh Benamar ,Ying Zhang ,Laryssa Manigat ,Tarek Abbas ,Jeongwu Lee ,Ichiro Nakano ,Jakub Godlewski ,Agnieszka Bronisz ,Roger Abounader ,Norbert Leitinger ,Benjamin Purow